{
  "Factual_Basis_of_Case": {
    "extracted": [
      {
        "evidence": [
          {
            "location": "Page 2",
            "source_document": "Complaint",
            "text": "Denka\u2019s neoprene manufacturing operations at the Pontchartrain Works Site in St. John the Baptist Parish, Louisiana (the \u201cFacility\u201d)"
          }
        ],
        "value": "Denka\u2019s neoprene manufacturing operations at the Pontchartrain Works Site in St. John the Baptist Parish, Louisiana (the \u201cFacility\u201d)"
      },
      {
        "evidence": [
          {
            "location": "Page 3",
            "source_document": "Complaint",
            "text": "average concentrations of chloroprene ... greater than 0.2 \u00b5g/m3 since at least 2016"
          }
        ],
        "value": "Average chloroprene concentrations at Denka\u2019s monitoring sites have been greater than 0.2 \u00b5g/m3 since at least 2016"
      },
      {
        "evidence": [
          {
            "location": "Page 14",
            "source_document": "Complaint",
            "text": "present an imminent and substantial endangerment to public health and welfare"
          }
        ],
        "value": "Chloroprene emissions from Denka\u2019s operations present an imminent and substantial endangerment to public health and welfare of surrounding communities"
      },
      {
        "evidence": [
          {
            "location": "Page 38",
            "source_document": "Complaint",
            "text": "EPA estimates that breathing chloroprene at concentrations averaging 0.2 \u00b5g/m3 over a 70\u2011year lifetime increases a person\u2019s risk of developing cancer by 1\u2011in\u201110,000"
          }
        ],
        "value": "EPA estimates that breathing chloroprene at concentrations averaging 0.2 \u00b5g/m3 over a 70\u2011year lifetime increases cancer risk by 1\u2011in\u201110,000"
      },
      {
        "evidence": [
          {
            "location": "Page 48",
            "source_document": "Complaint",
            "text": "average chloroprene concentration across all six Denka monitoring sites from April 2018 through January 2023 was approximately 1.46 \u00b5g/m3"
          }
        ],
        "value": "Average chloroprene concentration across all six Denka monitoring sites from April 2018 through January 2023 was approximately 1.46 \u00b5g/m3"
      },
      {
        "evidence": [
          {
            "location": "Page 49",
            "source_document": "Complaint",
            "text": "Western monitor ... 2.89 \u00b5g/m3"
          }
        ],
        "value": "The Western Denka monitoring site recorded 2.89 \u00b5g/m3, the highest concentration among the six sites"
      },
      {
        "evidence": [
          {
            "location": "Page 51",
            "source_document": "Complaint",
            "text": "average chloroprene concentration across all EPA monitoring sites from April 2018 through September 2020 was 1.43 \u00b5g/m3"
          }
        ],
        "value": "Average chloroprene concentration across all EPA monitoring sites from April 2018 through September 2020 was 1.43 \u00b5g/m3"
      },
      {
        "evidence": [
          {
            "location": "Page 52",
            "source_document": "Complaint",
            "text": "Chad Baker site ... 2.22 \u00b5g/m3"
          }
        ],
        "value": "The worst EPA monitoring site, Chad Baker, recorded 2.22 \u00b5g/m3"
      },
      {
        "evidence": [
          {
            "location": "Page 33",
            "source_document": "Complaint",
            "text": "Denka continues to emit approximately 18 tons of chloroprene each year"
          }
        ],
        "value": "Denka continues to emit approximately 18 tons of chloroprene each year"
      },
      {
        "evidence": [
          {
            "location": "Page 27",
            "source_document": "Complaint",
            "text": "Denka purchased the neoprene manufacturing operations at the Facility in 2014 from E.I. DuPont de Nemours and Company"
          }
        ],
        "value": "Denka purchased the neoprene manufacturing operations at the Facility in 2014 from E.I. DuPont de Nemours and Company"
      },
      {
        "evidence": [
          {
            "location": "Page 28",
            "source_document": "Complaint",
            "text": "Denka\u2019s emissions ... before April 2018 ... emitting more than one hundred tons of chloroprene each year"
          }
        ],
        "value": "Before April 2018, Denka\u2019s emissions were historically more than one hundred tons of chloroprene per year"
      },
      {
        "evidence": [
          {
            "location": "Page 13",
            "source_document": "Complaint",
            "text": "chloroprene concentrations ... still average well above 0.2 \u00b5g/m3"
          }
        ],
        "value": "Chloroprene concentrations around the Facility still average well above 0.2 \u00b5g/m3"
      },
      {
        "evidence": [
          {
            "location": "tokens 734-1659",
            "source_document": "Answer, Aff. Def. & Counterclaims",
            "text": "DPE admits only that 1,3-butadiene and chlorine are listed as hazardous air pollutants in the Clean Air Act if emitted into the atmosphere."
          }
        ],
        "value": "DPE admits that 1,3-butadiene and chlorine are listed as hazardous air pollutants in the Clean Air Act if emitted into the atmosphere."
      },
      {
        "evidence": [
          {
            "location": "tokens 734-1659",
            "source_document": "Answer, Aff. Def. & Counterclaims",
            "text": "EPA estimated that, assuming humans are as sensitive to chloroprene as the female B6C3F1 mouse, continuously breathing chloroprene at concentrations averaging one \u00b5g/m3 for 24 hours per day over a 70-year lifetime would produce five excess cancers per 10,000 people."
          }
        ],
        "value": "EPA\u2019s 2010 Toxicological Review estimated that continuously breathing chloroprene at 1\u202f\u00b5g/m\u00b3 for 24\u202fhrs/day over 70\u202fyears would produce five excess cancers per 10,000 people, based on an assumption that humans are as sensitive to chloroprene as the female B6C3F1 mouse."
      },
      {
        "evidence": [
          {
            "location": "tokens 734-1659",
            "source_document": "Answer, Aff. Def. & Counterclaims",
            "text": "DPE further avers that EPA\u2019s 2010 Review and resulting 0.2\u202f\u00b5g/m\u00b3 value for chloroprene are fundamentally flawed because, in setting that value, EPA relied upon a default assumption that humans are as sensitive to chloroprene as a female B6C3F1 mouse."
          }
        ],
        "value": "EPA\u2019s 2010 Review and the resulting 0.2\u202f\u00b5g/m\u00b3 risk value are fundamentally flawed because EPA relied on a default assumption that humans are as sensitive to chloroprene as a female B6C3F1 mouse, which overstates human cancer risk."
      },
      {
        "evidence": [
          {
            "location": "tokens 734-1659",
            "source_document": "Answer, Aff. Def. & Counterclaims",
            "text": "including (i) the use of the peer\u2011reviewed physiologically\u2011based pharmacokinetic (\u201cPBPK\u201d) model, developed (with EPA\u2019s support and collaboration) by scientists at Ramboll US Consulting, Inc.; (ii) the most recent and robust, and peer\u2011reviewed epidemiological study of chloroprene; and (iii) the empirical and state\u2011audited data from the Louisiana Tumor Registry showing cancer incidence rates in the community surrounding the Facility that are significantly lower than state\u2011wide averages."
          }
        ],
        "value": "EPA failed to consider best\u2011available scientific information, including the PBPK model developed by Ramboll, a peer\u2011reviewed epidemiological study of chloroprene, and Louisiana Tumor Registry data showing lower cancer incidence around the facility despite historical emissions."
      },
      {
        "evidence": [
          {
            "location": "tokens 734-1659",
            "source_document": "Answer, Aff. Def. & Counterclaims",
            "text": "emissions of chloroprene from the Facility (before it was owned by DPE) that were at least an order of magnitude higher than current emissions."
          }
        ],
        "value": "Historical emissions from the facility were at least an order of magnitude higher before DPE ownership, and emissions have since been substantially reduced."
      },
      {
        "evidence": [
          {
            "location": "tokens 172-650",
            "source_document": "Amended Counterclaim",
            "text": "DPE operates a manufacturing facility in La Place, Louisiana (the \u201cFacility\u201d) that uses a chemical called chloroprene to produce Neoprene, a popular synthetic rubber that is used in a wide array of products\u2026The Facility is the only Neoprene\u2011producing facility in the United States."
          }
        ],
        "value": "The facility uses chloroprene to produce neoprene and is the only neoprene\u2011producing facility in the United States."
      },
      {
        "evidence": [
          {
            "location": "tokens 172-650",
            "source_document": "Amended Counterclaim",
            "text": "EPA released a Toxicological Review of Chloroprene (the \u201c2010 Review\u201d) in which EPA calculated an \u201cinhalation unit risk\u201d (\u201cIUR\u201d) for human exposure to chloroprene of 5\u202f\u00d7\u202f10\u207b\u2074 per \u00b5g/m\u00b3 for 70\u2011years continuous exposure."
          }
        ],
        "value": "EPA\u2019s 2010 Review calculated an inhalation unit risk (IUR) of 5\u202f\u00d7\u202f10\u207b\u2074 per \u00b5g/m\u00b3 for 70\u2011year continuous exposure (chloroprene IUR)."
      },
      {
        "evidence": [
          {
            "location": "tokens 172-650",
            "source_document": "Amended Counterclaim",
            "text": "Based on the chloroprene IUR, EPA later declared that the chloroprene concentration associated with an incremental lifetime (i.e., 70\u2011year) cancer risk level of 1\u2011in\u201110,000 was 0.2\u202f\u00b5g/m\u00b3."
          }
        ],
        "value": "EPA later declared that the chloroprene concentration associated with a 1\u2011in\u201110,000 lifetime cancer risk level is 0.2\u202f\u00b5g/m\u00b3."
      },
      {
        "evidence": [
          {
            "location": "tokens 172-650",
            "source_document": "Amended Counterclaim",
            "text": "EPA has historically recognized that IUR values should be used only as a starting point for crafting emissions limits and that, when regulators develop such limits, they must consider the uncertainty inherent in IUR values along with a broad set of health risk measures and information."
          }
        ],
        "value": "EPA has historically recognized that IUR values should be used only as a starting point for crafting emissions limits."
      },
      {
        "evidence": [
          {
            "location": "tokens 734-1659",
            "source_document": "Answer, Aff. Def. & Counterclaims",
            "text": "Between 2017 and 2020, DPE reduced chloroprene emissions from the Facility by 85\u202fpercent (from 118 tons per year (\u201ctpy\u201d) to 18\u202ftpy) at a cost to DPE of more than $35\u202fmillion."
          }
        ],
        "value": "Between 2017 and 2020, DPE reduced chloroprene emissions from the Facility by 85\u202f% (from 118\u202ftpy to 18\u202ftpy) at a cost to DPE of more than $35\u202fmillion."
      }
    ],
    "key": "Factual_Basis_of_Case",
    "last_updated": "2025-11-20T10:23:22.798115-05:00"
  }
}